Subazole: Pivotal trial started

Halcygen began a U.S. pivotal pharmacokinetic study to evaluate oral SUBA-Itraconazole and Sporanox itraconazole from Johnson & Johnson (NYSE:JNJ, New Brunswick, N.J.). Halcygen has exclusive worldwi...